Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Innolake Biopharm

Request full access

A clinical stage biotech company, dedicated to developing innovative medicines against cancer and autoimmune diseases

Hangzhou, ChinaFounded 2020Biotech & Life Sciences

About Innolake Biopharm

Innolake Biopharm is a clinical-stage biopharmaceutical company headquartered in Hangzhou, China, with a business operation center in Shanghai. Founded in December 2020 by Dr. Mingde Xia and Robert Chen, the company develops innovative medicines for cancer and autoimmune diseases. Its R&D pipeline spans antibody-drug conjugates (ADCs), biologics and small-molecule programs built on proprietary technology platforms, with more than ten drug candidates in development, two of which have entered the clinical stage. Innolake combines in-house research and development with strategic partnerships with multinational pharmaceutical and biotech companies, including collaborations with WuXi Biologics and Ellipses Pharma on ADC development. The company serves patients with unmet medical needs in oncology and immunology across the Chinese and global biopharmaceutical markets.

Source: Dealroom company data

At a glance

Status
Operational
Employees
5
Open positions
None listed
Dealroom signal
57.4/100
Industry
Health
Sub-industry
BioTechnology
Sector
Biotechnology, Biotech and Pharma, DT and LS, science-based
Business model
Manufacturing
Client focus
B2B

Funding history

2 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
SERIES AOther financing Jun 2023 $14M $55M WuXi Biologics · Zhongbo Juli · Hangzhou Heda Industry Fund ↗
SEEDOther financing Jan 2021 $41M $165M CDH Investments · Huagai Capital · WuXi Biologics ↗
Showing the latest 2 of 2 recorded eventsBook a demo for the full funding history →

Growth signals

Innolake Biopharm website traffic

Latest recorded traffic for Innolake Biopharm is 370 monthly website visits, down 50.7% over the last three months. Innolake Biopharm's team grew 0% over the past year.

Latest monthly visits370 3-month web change-50.7% 1-year team growth0%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Innolake Biopharm in the Hangzhou ecosystem

Live from Dealroom

The Innolake Biopharm office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

5 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Seed3 investors entered at this stage

Series A2 investors entered at this stage

  • Zhongbo Juli
  • Hangzhou Heda Industry Fund
Team profiled 1 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 1 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
1 countries with
team presence
🇨🇳 China100%
1 country shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Innolake Biopharm on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Innolake Biopharm’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.